| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 23.781 | 30.186 | 60.797 | 122.209 | 179.567 | 232.292 | 184.170 | 192.136 | 171.980 | 180.951 |
| Total Income - EUR | 23.781 | 31.020 | 61.633 | 122.989 | 180.018 | 232.645 | 186.429 | 194.362 | 173.802 | 183.687 |
| Total Expenses - EUR | 19.114 | 13.735 | 56.330 | 116.707 | 168.895 | 200.449 | 184.164 | 180.990 | 169.482 | 181.388 |
| Gross Profit/Loss - EUR | 4.668 | 17.284 | 5.303 | 6.282 | 11.123 | 32.196 | 2.265 | 13.372 | 4.320 | 2.299 |
| Net Profit/Loss - EUR | 3.954 | 16.358 | 4.695 | 5.059 | 9.327 | 30.056 | 440 | 11.624 | 2.780 | 1.525 |
| Employees | 2 | 2 | 2 | 3 | 4 | 4 | 3 | 3 | 3 | 3 |
Check the financial reports for the company - Aseptica Pharma Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 2.259 | 5.368 | 5.135 | 3.117 | 2.972 | 4.204 | 7.874 | 5.461 | 15.356 | 14.004 |
| Current Assets | 8.309 | 26.742 | 57.674 | 71.352 | 83.792 | 96.789 | 89.829 | 106.791 | 102.155 | 97.170 |
| Inventories | 12 | 6.433 | 31.704 | 31.595 | 32.863 | 38.128 | 32.433 | 35.669 | 39.714 | 27.762 |
| Receivables | 2.989 | 7.275 | 19.274 | 37.885 | 45.364 | 49.994 | 38.218 | 45.924 | 40.182 | 48.564 |
| Cash | 5.308 | 13.034 | 6.696 | 1.872 | 5.565 | 8.666 | 19.177 | 25.197 | 22.260 | 20.844 |
| Shareholders Funds | 14.598 | 19.810 | 24.170 | 28.785 | 37.554 | 66.898 | 65.854 | 77.683 | 80.228 | 81.305 |
| Social Capital | 63 | 312 | 306 | 301 | 295 | 289 | 283 | 284 | 283 | 281 |
| Debts | 1.636 | 17.951 | 44.099 | 51.377 | 55.043 | 40.339 | 40.601 | 47.517 | 50.192 | 42.706 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Aseptica Pharma Srl